Navigation Links
Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration
Date:10/30/2008

l milestones expected to be reached by the third quarter of 2009.

Through its IDDP program, JDRF has funded some 25 companies, representing approximately $29 million in diabetes science.

"Our partnership with Bayhill Therapeutics reflects JDRF's commitment to accelerating the pace of science leading to a cure for type 1 diabetes," said Dr. Richard A. Insel, JDRF Executive Vice President, Research. "Bayhill's DNA vaccine protocol has the potential to negate the autoimmune process causing type 1 diabetes, which must be addressed to cure the disease."

About T1D

Type 1 diabetes is an autoimmune disease that results from the immune system attacking and destroying insulin-producing cells in the pancreas. It affects children, adolescents, and adults, and last for life. Tight control of blood glucose is critical to both the long- and short-term health of patients. Short-term effects of poor glucose control include diabetic ketoacidosis, which is a condition that can lead to coma. Long-term effects include elevated glucose levels, blindness, kidney disease, heart disease, peripheral vascular disease and stroke. In order to keep blood glucose at or near normal levels, patients require the life-long administration of insulin, which is the only approved therapy for type 1 diabetes.

About BHT-3021

BHT-3021 is a plasmid encoding proinsulin designed to tolerize the immune system, thereby turning off the self directed immune attack against the islet cells. This product candidate's potential to stabilize or improve glucose control by eliminating the autoimmune response could lead to reduced insulin dependence and long-term complications of type 1 diabetes.

Patient enrollment is currently underway in a Phase I/II placebo-controlled clinical trial of BHT-3021 to evaluate safety, pharmacodynamics, immune tolerance and pancreatic function in patients with T1D. Preliminary data from the trial have been pos
'/>"/>

Contact: Leslie Schwartz
lschwartz@jdrf.org
212-479-7553
Juvenile Diabetes Research Foundation International
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
2. Michael J. Fox Foundation PD Therapeutics Conference
3. CU-Boulder, biotech firm team up on python project in search for human cardiac therapeutics
4. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
5. Sirtris review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
6. Growing fuel and medicine: Advancing biofuels and plant-produced therapeutics
7. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
8. Gender, coupled with diabetes, affects vascular disease development
9. Breakthrough research identifies how cells from pigs may cure diabetes
10. Botched production of insulin molecule may lead to diabetes
11. Joslin researchers uncover potential role of leptin in diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... the repeated climatic shifts over the last 120,000 ... diversity, a team of researchers led by City ... developed a new biodiversity metric called "phylogeographic endemism." ... genetic variation within species is restricted in geographical ... biology, and 14 other researchers from institutions in ...
(Date:8/29/2014)... species of marine phytoplankton, such as the prolific bloomer ... B1 (thiamine), researchers have discovered. The finding contradicts the ... other eukaryotic microbes depend on scarce supplies of thiamine ... different way to think about the ocean," says CIFAR ... The ISME Journal paper with CIFAR fellows ...
(Date:8/28/2014)... Invasives is now available from the Lady Bird Johnson ... for identifying harmful non-native plant, insect and other invasive ... States cause about $137 billion in economic and other ... kill native plants and more. , "By having streamlined ... invasive species occur, we,re more likely to catch these ...
Breaking Biology News(10 mins):CCNY team defines new biodiversity metric 2Not all phytoplankton in the ocean need to take their vitamins 2Not all phytoplankton in the ocean need to take their vitamins 3Mobile app makes ID of harmful plants, insects in Texas a snap 2
... Israel,s Wolf Foundation, whose stated mission is "to ... has named Whitehead Institute Founding Member Rudolf Jaenisch a ... Jaenisch will share this year,s prize with Kyoto ... as "their groundbreaking contribution to stem cell research." ...
... 10, 2011 Based on its recent analysis ... Sullivan recognizes Cardiocom with the 2011 North American ... provides integrated clinical telehealth services that offer significant ... (Logo:   http://photos.prnewswire.com/prnh/20081117/FSLOGO ) Cardiocom combines ...
... N.J. and REDWOOD CITY, Calif., Jan. 12, 2011 ... Codexis, custom biocatalysts and services, and secures supply ... pharmaceutical manufacturing routes developed by DSM,s InnoSyn™ route ... of new efficient manufacturing processes for active pharmaceutical ...
Cached Biology News:Whitehead member Rudolf Jaenisch honored for groundbreaking stem cell research 2Frost & Sullivan Recognizes Cardiocom as a Technology Enabler for Superior Cost-Effective Remote Chronic Care Management 2Frost & Sullivan Recognizes Cardiocom as a Technology Enabler for Superior Cost-Effective Remote Chronic Care Management 3Frost & Sullivan Recognizes Cardiocom as a Technology Enabler for Superior Cost-Effective Remote Chronic Care Management 4DSM and Codexis Sign Enzyme Supply Agreement 2DSM and Codexis Sign Enzyme Supply Agreement 3DSM and Codexis Sign Enzyme Supply Agreement 4
(Date:9/1/2014)... 2014 The Collaborative R&D Terms ... provides comprehensive understanding and unprecedented access to the ... the worlds leading life science companies. , The ... how and why companies enter collaborative R&D deals. ... negotiated deals terms provides critical insight into the ...
(Date:8/30/2014)... (PRWEB) August 31, 2014 The ... a professional and in-depth study on the current ... Global and China. , The report provides a ... and industry chain structure. Global market analysis and ... focus on history, developments, trends and competitive landscape ...
(Date:8/29/2014)... August 29, 2014 Pittcon is pleased ... and colleague Koichiro Matsuda, Horiba Scientific, have organized a ... 5, 2014. JASIS , Asia’s largest analytical and ... in Makuhari Messe, Japan. , The four speakers ... Bioanalysis from Single Molecules to Single Cells” will present ...
(Date:8/29/2014)... August 29, 2014 A major challenge ... biotech start-up dense realm of Boston-Cambridge, is gaining visibility ... investors. James Sherley, the Director of Boston’s Adult Stem ... local and national visibility of his company an important ... , In addition to a social media marketing ...
Breaking Biology Technology:Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 3Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 4Electrical Insulating Varnish Market World, China Regional Analysis & 2020 Forecasts Available at DeepResearchReports.com 2Electrical Insulating Varnish Market World, China Regional Analysis & 2020 Forecasts Available at DeepResearchReports.com 3Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4
... ON, Oct. 14 /PRNewswire/ - Vineland Research ... to create a,world-class centre for horticultural science ... of Dr. Daryl Somers to the new ... for the Centre., "Vineland is determined ...
... In-House Biologic Product to Debut at NASS, GREENVILLE, ... Inc. today announced the U.S. market release of their,FortrOss ... public,debut at the 23rd Annual Meeting of the North ... void filler, utilizing the power of,nanotechnology for orthopaedic applications, ...
... today,announces that Mr. Mark Sutherland has joined GenVault ... Sutherland will be responsible for,finding, prioritizing and closing ... and technologies as well as developing,a series of ... 25 years experience in life sciences,business development, sales ...
Cached Biology Technology:Vineland Welcomes Dr. Daryl Somers as Research Chair, Molecular Breeding and Biotechnology 2Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler 2Mark Sutherland Joins GenVault as Senior Vice President, Business Development 2
... LX80L is an extension of Parkers MX80 family ... compact cross-section. LX80L bolt hole patterns mimic the ... units and all accessory brackets to build multi-axis ... travel to 750 mm , Accelerations to 5 ...
... from the C-terminal end of the mouse retinoic acid receptor beta (RAR*). ... 448 of RAR*. The sequence of PEP-005 is (amino to carboxy ... - S - S - V - E - N - S ... - L - L - Q (The N-terminal cysteine has been ...
... Neural Stem Cell Kit with Medium High ... complete with optimized base medium for growth ... these unique cells generated from E18 fetal ... for a tissue-like mixture of in vitro ...
... The potential applications for the use of ... gene expression via the RNA interference (RNAi) ... cellular and molecular biology fields. siRNA for ... either chemically or enzymatically, and then transfected ...
Biology Products: